Bio-modified Fe3O4core/Au shell nanoparticles for targeting and multimodal imaging of cancer cells

2012 ◽  
Vol 22 (2) ◽  
pp. 470-477 ◽  
Author(s):  
Ting Zhou ◽  
Baoyan Wu ◽  
Da Xing
2013 ◽  
Vol 13 (6) ◽  
pp. 2341-2347 ◽  
Author(s):  
Luca Menichetti ◽  
Leonardo Manzoni ◽  
Luigi Paduano ◽  
A. Flori ◽  
Claudia Kusmic ◽  
...  

RSC Advances ◽  
2016 ◽  
Vol 6 (54) ◽  
pp. 48379-48386 ◽  
Author(s):  
Xiaolin Li ◽  
Zhi Yang ◽  
Nantao Hu ◽  
Liying Zhang ◽  
Yafei Zhang ◽  
...  

The multifunctional antitumor SiO2@Au@GO core–shell nanoparticles (NPs) have been fabricated for serving as drug nanocarrier and photothermal inducer to have a treatment on human prostate cancer cell DU 145.


2019 ◽  
Vol 30 (31) ◽  
pp. 315701 ◽  
Author(s):  
Alexandru-Milentie Hada ◽  
Monica Potara ◽  
Sorina Suarasan ◽  
Adriana Vulpoi ◽  
Timea Nagy-Simon ◽  
...  

RSC Advances ◽  
2014 ◽  
Vol 4 (40) ◽  
pp. 20641-20648 ◽  
Author(s):  
Babao Lin ◽  
Xiuzhong Yao ◽  
Yihua Zhu ◽  
Jianhua Shen ◽  
Xiaoling Yang ◽  
...  

Multifunctional gadolinium-labeled silica-coated core/shell nanoparticles with high relaxivity and photoluminescence were synthesized for dual-modal contrast.


2008 ◽  
Vol 8 (5) ◽  
pp. 2488-2491 ◽  
Author(s):  
Jing-Liang Li ◽  
Xiang-Yang Liu

Selenium-polypyrrole core–shell nanoparticles are fabricated by an in-situ polymerization process and functionalized with transferrin for targeting and imaging of human cervical cancer cells. The shell thickness and chemical composition of the as-synthesized particles can be manipulated by controlling the precursor concentration. The presence of the polymer layer can greatly increase the thermal stability of the selenium nanoparticles. The presence of transferrin molecules on the surface of the core–shell nanoparticles can significantly enhance their cellular uptake. The tranferrin-conjugated core–shell nanoparticles can be potentially used for the targeting and imaging of cancer cells.


Nanomaterials ◽  
2020 ◽  
Vol 10 (7) ◽  
pp. 1351
Author(s):  
Che-Wei Hsu ◽  
Nai-Chi Cheng ◽  
Mei-Yi Liao ◽  
Ting-Yu Cheng ◽  
Yi-Chun Chiu

Photodynamic therapy (PDT) is a promising treatment for malignancy. However, the low molecular solubility of photosensitizers (PSs) with a low accumulation at borderline malignant potential lesions results in the tardy and ineffective management of recurrent urothelial carcinoma. Herein, we used tannic acid (TNA), a green precursor, to reduce HAuCl4 in order to generate Au@TNA core-shell nanoparticles. The photosensitizer methylene blue (MB) was subsequently adsorbed onto the surface of the Au@TNA nanoparticles, leading to the incorporation of a PS within the organic shell of the Au nanoparticle nanosupport, denoted as Au@TNA@MB nanoparticles (NPs). By modifying the surface of the Au@TNA@MB NPs with the ligand folate acid (FA) using NH2-PEG-NH2 as a linker, we demonstrated that the targeted delivery strategy achieved a high accumulation of PSs in cancer cells. The cell viability of T24 cells decreased to 87.1%, 57.1%, and 26.6% upon treatment with 10 ppm[Au] Au@TNA/MB NPs after 45 min, 2 h, and 4 h of incubation, respectively. We also applied the same targeted PDT treatment to normal urothelial SV-HUC-1 cells and observed minor phototoxicity, indicating that this safe photomedicine shows promise for applications aiming to achieve the local depletion of cancer sites without side effects.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Pengcheng Xu ◽  
Ru Wang ◽  
Wenqian Yang ◽  
Yanyan Liu ◽  
Dongsheng He ◽  
...  

Abstract Background Although many treatments for breast cancer are available, poor tumour targeting limits the effectiveness of most approaches. Consequently, it is difficult to achieve satisfactory results with monotherapies. The lack of accurate diagnostic and monitoring methods also limit the benefits of cancer treatment. The aim of this study was to design a nanocarrier comprising porous gold nanoshells (PGNSs) co-decorated with methoxy polyethylene glycol (mPEG) and trastuzumab (Herceptin®, HER), a therapeutic monoclonal antibody that binds specifically to human epidermal receptor-2 (HER2)-overexpressing breast cancer cells. Furthermore, a derivative of the microtubule-targeting drug maytansine (DM1) was incorporated in the PGNSs. Methods Prepared PGNSs were coated with mPEG, DM1 and HER via electrostatic interactions and Au–S bonds to yield DM1-mPEG/HER-PGNSs. SK-BR-3 (high HER2 expression) and MCF-7 (low HER2) breast cancer cells were treated with DM1-mPEG/HER-PGNSs, and cytotoxicity was evaluated in terms of cell viability and apoptosis. The selective uptake of the coated PGNSs by cancer cells and subsequent intracellular accumulation were studied in vitro and in vivo using inductively coupled plasma mass spectrometry and fluorescence imaging. The multimodal imaging feasibility and synergistic chemo-photothermal therapeutic efficacy of the DM1-mPEG/HER-PGNSs were investigated in breast cancer tumour-bearing mice. The molecular mechanisms associated with the anti-tumour therapeutic use of the nanoparticles were also elucidated. Result The prepared DM1-mPEG/HER-PGNSs had a size of 78.6 nm and displayed excellent colloidal stability, photothermal conversion ability and redox-sensitive drug release. These DM1-mPEG/HER-PGNSs were taken up selectively by cancer cells in vitro and accumulated at tumour sites in vivo. Moreover, the DM1-mPEG/HER-PGNSs enhanced the performance of multimodal computed tomography (CT), photoacoustic (PA) and photothermal (PT) imaging and enabled chemo-thermal combination therapy. The therapeutic mechanism involved the induction of tumour cell apoptosis via the activation of tubulin, caspase-3 and the heat shock protein 70 pathway. M2 macrophage suppression and anti-metastatic functions were also observed. Conclusion The prepared DM1-mPEG/HER-PGNSs enabled nanodart-like tumour targeting, visibility by CT, PA and PT imaging in vivo and powerful tumour inhibition mediated by chemo-thermal combination therapy in vivo. In summary, these unique gold nanocarriers appear to have good potential as theranostic nanoagents that can serve both as a probe for enhanced multimodal imaging and as a novel targeted anti-tumour drug delivery system to achieve precision nanomedicine for cancers.


2019 ◽  
Vol 7 (24) ◽  
pp. 3856-3864 ◽  
Author(s):  
Mengxue Liu ◽  
Jiulong Zhang ◽  
Xin Li ◽  
Chao Cai ◽  
Xueyan Cao ◽  
...  

A novel targeted theranostic nanoplatform (LAP–Fe3O4@PDA–PEG–PBA) is constructed for magnetic resonance and photoacoustic imaging-guided photothermal therapy of cancer cells overexpressing sialic acid.


Sign in / Sign up

Export Citation Format

Share Document